Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by fivenineon Feb 24, 2017 1:33pm

181 Views

Post# 25890184

RE:RE:RE:Not impressed.....

Those results are for the small initial phase one trial in Edmonton a few years ago. No news there. Primary endpoints were safety and bio-compatibility, which were met...efficacy was not even a primary endpoint, although I have heard at the end of the trial period, one of the three patients refused to allow the removal of the Cell Pouch.

Sernova are in the process of starting a larger scale phase 1/2 clinical trial in the USA, due to commence in 2017.

Watch this clip:

https://soundcloud.com/levine-media-group/sernova-eyes-range-of-disease-for-implantable-cell-technology

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?